<VariationArchive VariationID="1069435" VariationName="NM_000528.4(MAN2B1):c.53_69dup (p.Met24fs)" VariationType="Duplication" Accession="VCV001069435" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064639" VariationID="1069435">
      <GeneList>
        <Gene Symbol="LOC130063650" FullName="ATAC-STARR-seq lymphoblastoid silent region 10156" GeneID="130063650" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12666605" stop="12666884" display_start="12666605" display_stop="12666884" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MAN2B1" FullName="mannosidase alpha class 2B member 1" GeneID="4125" HGNC_ID="HGNC:6826" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12646512" stop="12666742" display_start="12646512" display_stop="12666742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12757321" stop="12777590" display_start="12757321" display_stop="12777590" Strand="-" />
          </Location>
          <OMIM>609458</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000528.4(MAN2B1):c.53_69dup (p.Met24fs)</Name>
      <CanonicalSPDI>NC_000019.10:12666632:GGTCCAGGGGCCTGCTG:GGTCCAGGGGCCTGCTGGGTCCAGGGGCCTGCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12666632" stop="12666633" display_start="12666632" display_stop="12666633" variantLength="17" positionVCF="12666632" referenceAlleleVCF="T" alternateAlleleVCF="TGGTCCAGGGGCCTGCTG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12777446" stop="12777447" display_start="12777446" display_stop="12777447" variantLength="17" positionVCF="12777446" referenceAlleleVCF="T" alternateAlleleVCF="TGGTCCAGGGGCCTGCTG" />
      </Location>
      <ProteinChange>M24fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.12666633_12666649dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.12666633_12666649dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.12777447_12777463dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.12777447_12777463dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008318.1" sequenceAccession="NG_008318" sequenceVersion="1" change="g.5129_5145dup">
            <Expression>NG_008318.1:g.5129_5145dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015814.1" sequenceAccession="NG_015814" sequenceVersion="1" change="g.4830_4846dup">
            <Expression>NG_015814.1:g.4830_4846dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000528.4" sequenceAccession="NM_000528" sequenceVersion="4" change="c.53_69dup" MANESelect="true">
            <Expression>NM_000528.4:c.53_69dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000519.2" sequenceAccession="NP_000519" sequenceVersion="2" change="p.Met24fs">
            <Expression>NP_000519.2:p.Met24fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001173498.2" sequenceAccession="NM_001173498" sequenceVersion="2" change="c.53_69dup">
            <Expression>NM_001173498.2:c.53_69dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166969.1" sequenceAccession="NP_001166969" sequenceVersion="1" change="p.Met24fs">
            <Expression>NP_001166969.1:p.Met24fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2145294424" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000528.4(MAN2B1):c.53_69dup (p.Met24fs) AND Deficiency of alpha-mannosidase" Accession="RCV001381300" Version="4">
        <ClassifiedConditionList TraitSetID="428">
          <ClassifiedCondition DB="MedGen" ID="C0024748">Deficiency of alpha-mannosidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-06-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22161967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9915946</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="428" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alpha-Mannosidosis</ElementValue>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal alpha-D-mannosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha mannosidase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mannosidosis, alpha B lysosomal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of alpha-mannosidase</ElementValue>
                <XRef ID="Alpha-Mannosidosis+Type+1/332" DB="Genetic Alliance" />
                <XRef ID="124466001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MANSA</ElementValue>
                <XRef Type="MIM" ID="248500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6968" />
                <XRef ID="6968" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-mannosidosis encompasses a continuum of clinical findings from mild to severe. Three major clinical subtypes have been suggested: A mild form recognized after age ten years with absence of skeletal abnormalities, myopathy, and slow progression (type 1). A moderate form recognized before age ten years with presence of skeletal abnormalities, myopathy, and slow progression (type 2). A severe form manifested as prenatal loss or early death from progressive central nervous system involvement or infection (type 3). Individuals with a milder phenotype have mild-to-moderate intellectual disability, impaired hearing, characteristic coarse features, clinical or radiographic skeletal abnormalities, immunodeficiency, and primary central nervous system disease â€“ mainly cerebellar involvement causing ataxia. Periods of psychiatric symptoms are common. Associated medical problems can include corneal opacities, hepatosplenomegaly, aseptic destructive arthritis, and metabolic myopathy. Alpha-mannosidosis is insidiously progressive; some individuals may live into the sixth decade.</Attribute>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301570</ID>
                <ID Source="BookShelf">NBK1396</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21368911</ID>
              </Citation>
              <XRef ID="61" DB="Orphanet" />
              <XRef ID="C0024748" DB="MedGen" />
              <XRef ID="MONDO:0009561" DB="MONDO" />
              <XRef Type="MIM" ID="248500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3105229" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10944459|MedGen:C0024748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579623" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9915946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22161967</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant has not been reported in the literature in individuals with MAN2B1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Met24Glnfs*46) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAN2B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.12777446_12777447insGGTCCAGGGGCCTGCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3105229" TraitType="Disease" MappingType="XRef" MappingValue="C0024748" MappingRef="MedGen">
        <MedGen CUI="C0024748" Name="Deficiency of alpha-mannosidase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

